G8935 HCPCS Level II code: Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy
G8935 is the HCPCS code for “Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
G8935Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy
Short description: Rx ace or arb therapy
HCPCS · United States
Medicare details
The indicators CMS publishes with G8935 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
- Type of service
- Medical care
- BETOS category
- Specialist - psychiatry
- Added
- Jan 1, 2013
Where G8935 sits
- 1G codesProcedures and professional services
- 2Active code G8935Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code G8935 mean?
G8935 is the HCPCS code for “Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover G8935?
CMS lists G8935’s Medicare coverage as “Carrier judgment” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside G8935
All G codesG8929Adjuvant chemotherapy not prescribed or previously received, reason not givenG8930Assessment of depression severity at the initial evaluationG8931Assessment of depression severity not documented, reason not givenG8932Suicide risk assessed at the initial evaluationG8933Suicide risk not assessed at the initial evaluation, reason not givenG8934Current or prior left ventricular ejection fraction (lvef) <=40% or documentation of moderately or severely depressed left ventricular systolic functionG8936Clinician documented that patient was not an eligible candidate for angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy (eg, allergy…G8937Clinician did not prescribe angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy, reason not givenG8938Bmi is documented as being outside of normal parameters, follow-up plan is not documented, documentation the patient is not eligibleG8939Pain assessment documented as positive, follow-up plan not documented, documentation the patient is not eligible at the time of the encounterG8940Screening for depression documented as positive, a follow-up plan not completed, documented reasonG8941Elder maltreatment screen documented as positive, follow-up plan not documented, documentation the patient is not eligible for follow-up plan at the time of the encounter